Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease

NCT00852787 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

NIH

Sponsor class

Conditions

Hypertension
Hemodialysis

Interventions

DRUG: Digoxin immune fab
DRUG: Placebo

Sponsor

National Institute on Aging (NIA)

Collaborators

[object Object]